The ASCO Direct Highlights™ 2023 Miami Symposium is a summarized version of the ASCO Annual Conference made available locally to simulate attendance for those who may not have the resources or time to attend the national conference. MCI obtained in 2014 the first official license to conduct ASCO Direct Highlights™, giving oncologists the opportunity to increase their knowledge about cancer, improve their competence, and enhance practice performance and patient care. ASCO DIRECT HIGHLIGHTS will provide an evidence-based, state-of-the-art educational activity that will assist clinicians in making up-to-date, appropriate treatment decisions. One of the most important goals is to help the physicians to incorporate in their daily practices the latest and best of oncology care as presented and discussed every year in ASCO –the most important cancer meeting in the world with more than 37,000 people attending every year.
Objectives
At the conclusion of this activity, learners will be able to:
- Review advances in clinical and translational cancer research with the information presented during the 2023 ASCO® Annual Meeting
- Evaluate the role of new diagnostic techniques and therapeutic approaches as applied to the care and management of patients with cancer
- Discuss the latest clinical trials that have influenced the changes in standards of oncology care both in the U.S. and globally
- Obtain a comprehensive and state of the art review of hematology, oncology, surgical oncology, and radiation oncology developments
- Implement new patient management and supportive care strategies or revise existing ones
